<?xml version="1.0" encoding="UTF-8"?>
<ref id="B25">
 <label>25.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Stadler</surname>
    <given-names>WM</given-names>
   </name>, 
   <name name-style="western">
    <surname>Vogelzang</surname>
    <given-names>NJ</given-names>
   </name>, 
   <name name-style="western">
    <surname>Amato</surname>
    <given-names>R</given-names>
   </name>, 
   <name name-style="western">
    <surname>Sosman</surname>
    <given-names>J</given-names>
   </name>, 
   <name name-style="western">
    <surname>Taber</surname>
    <given-names>D</given-names>
   </name>, 
   <name name-style="western">
    <surname>Liebowitz</surname>
    <given-names>D</given-names>
   </name>, 
   <name name-style="western">
    <surname>Vokes</surname>
    <given-names>EE</given-names>
   </name>
  </person-group>
  <year>2000</year>
  <article-title>Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago phase II consortium study</article-title>. 
  <source>J Clin Oncol</source>
  <volume>18</volume>:
  <fpage>371</fpage>â€“
  <lpage>375</lpage>. doi:
  <pub-id pub-id-type="doi">10.1200/JCO.2000.18.2.371</pub-id>.
  <pub-id pub-id-type="pmid">10637252</pub-id>
 </mixed-citation>
</ref>
